loader image

VIRAGE Newsletter May Issue

As part of the VIRAGE initiative, 25 Focus Group Discussions were conducted across Cambodia between March and May 2026, bringing together 254 human and animal health professionals. The consultations identified key challenges in rabies surveillance, reporting, PEP accessibility, and dog population management, while highlighting the need for stronger coordination, training, and community engagement. These insights … Read more

Joint meeting of the DATURA DSMB and Project Steering Committee Held in Montpellier, France

[English Below]αž€αž·αž…αŸ’αž…αž”αŸ’αžšαž‡αž»αŸ†αžšαž½αž˜αž‚αŸ’αž“αžΆαžšαžœαžΆαž„αž‚αžŽαŸˆαž€αž˜αŸ’αž˜αžΆαž’αž·αž€αžΆαžšαžαŸ’αžšαž½αžαž–αž·αž“αž·αžαŸ’αž™αž‘αž·αž“αŸ’αž“αž“αŸαž™ αž“αž·αž„αžŸαž»αžœαžαŸ’αžαž·αž—αžΆαž– (DSMB) αž“αž·αž„αž‚αžŽαŸˆαž€αž˜αŸ’αž˜αžΆαž’αž·αž€αžΆαžšαžŠαžΉαž€αž“αžΆαŸ†αž‚αž˜αŸ’αžšαŸ„αž„ DATURA αžŠαŸ‚αž›αž”αžΆαž“αž”αŸ’αžšαž–αŸ’αžšαžΉαžαŸ’αžαž‘αŸ…αž“αŸ…αž‘αžΈαž€αŸ’αžšαž»αž„ Montpellier αž”αŸ’αžšαž‘αŸαžŸαž”αžΆαžšαžΆαŸ†αž„αž‚αž˜αŸ’αžšαŸ„αž„αžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαžœαŸαž‡αŸ’αž‡αžŸαžΆαžŸαŸ’αžαŸ’αžš DATURA (NCT04738812) αž”αžΆαž“αžˆαžΆαž“αžŠαž›αŸ‹αžŠαŸ†αžŽαžΆαž€αŸ‹αž€αžΆαž›αžŠαŸαžŸαŸ†αžαžΆαž“αŸ‹αž˜αž½αž™ αž‚αžΊαž€αžΆαžšαž”αž‰αŸ’αž…αž”αŸ‹αž€αžΆαžšαžœαž·αž—αžΆαž‚αž‘αž·αž“αŸ’αž“αž“αŸαž™ αž“αž·αž„αž€αžΆαžšαž–αž·αž“αž·αžαŸ’αž™αž‘αžΎαž„αžœαž·αž‰αž“αžΌαžœαž›αž‘αŸ’αž’αž•αž›αž”αž‹αž˜ αž€αŸ’αž“αž»αž„αž’αŸ†αž‘αž»αž„αž–αŸαž›αž€αž·αž…αŸ’αž…αž”αŸ’αžšαž‡αž»αŸ† αž‚αžŽαŸˆαž€αž˜αŸ’αž˜αžΆαž’αž·αž€αžΆαžšαžŠαžΉαž€αž“αžΆαŸ†αž‚αž˜αŸ’αžšαŸ„αž„ αž“αŸ…αž‘αžΈαž€αŸ’αžšαž»αž„ Montpellier αž”αŸ’αžšαž‘αŸαžŸαž”αžΆαžšαžΆαŸ†αž„ αž€αžΆαž›αž–αžΈαžαŸ’αž„αŸƒαž‘αžΈ ្៧-្៨ αžαŸ‚αž˜αŸαžŸαžΆ αž†αŸ’αž“αžΆαŸ† αŸ’αŸ αŸ’αŸ¦αŸ”αž€αŸ’αžšαŸ„αž˜αž€αžΆαžšαž§αž”αžαŸ’αžαž˜αŸ’αž—αžαžœαž·αž€αžΆαžŠαŸ„αž™ ANRS αž“αž·αž„ EDCTP2 αž‚αž˜αŸ’αžšαŸ„αž„ DATURA αž‚αžΊαž‡αžΆαž€αžΆαžšαžŸαžΆαž€αž›αŸ’αž”αž„αž‚αŸ’αž›αžΈαž“αž·αž€αž’αž“αŸ’αžαžšαž‡αžΆαžαž·αžŠαŸ†αžŽαžΆαž€αŸ‹αž€αžΆαž›αž‘αžΈ ៣ (Phase III clinical trial) αžŠαŸ‚αž›αžαŸ’αžšαžΌαžœαž”αžΆαž“αž’αž“αž»αžœαžαŸ’αžαž“αŸ…αž€αŸ’αž“αž»αž„αž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆ αž“αž·αž„αž”αŸ’αžšαž‘αŸαžŸαž…αŸ†αž“αž½αž“ αŸ₯ αž‘αŸ€αžαž€αŸ’αž“αž»αž„αž‘αŸ’αžœαžΈαž”αž’αžΆαž αŸ’αžœαŸ’αžšαž·αž€ αžšαž½αž˜αž˜αžΆαž“αŸ– αž”αŸ’αžšαž‘αŸαžŸαž€αžΆαž˜αŸαžšαžΌαž“ αž αŸ’αž‚αžΈαžŽαŸ αž’αŸŠαžΌαž αŸ’αž‚αž„αŸ‹αžŠαžΆ αž αŸ’αžŸαžΆαŸ†αž”αŸŠαžΈ αž“αž·αž„αž˜αŸ‰αžΌαžŸαŸ†αž”αŸŠαžΈαž€αŸ” αž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆαž“αŸαŸ‡αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„αžœαžΆαž™αžαž˜αŸ’αž›αŸƒαžαžΆ αžαžΎαž€αžΆαžšαž–αŸ’αž™αžΆαž”αžΆαž›αž‡αŸ†αž„αžΊαžšαž”αŸαž„αž€αŸ’αž“αž»αž„αž€αž˜αŸ’αžšαž·αžαžαŸ’αž›αžΆαŸ†αž„ (intensified treatment) αž’αžΆαž…αž€αžΆαžαŸ‹αž”αž“αŸ’αžαž™αž’αžαŸ’αžšαžΆαž˜αžšαžŽαž—αžΆαž–αž€αŸ’αž“αž»αž„αž…αŸ†αžŽαŸ„αž˜αž˜αž“αž»αžŸαŸ’αžŸαž–αŸαž‰αžœαŸαž™ αž“αž·αž„αž˜αž“αž»αžŸαŸ’αžŸαžœαŸαž™αž‡αŸ†αž‘αž„αŸ‹αžŠαŸ‚αž›αžŸαž˜αŸ’αžšαžΆαž€αž–αŸ’αž™αžΆαž”αžΆαž›αž€αŸ’αž“αž»αž„αž˜αž“αŸ’αž‘αžΈαžšαž–αŸαž‘αŸ’αž™ αž αžΎαž™αž˜αžΆαž“αž•αŸ’αž‘αž»αž€αž˜αŸαžšαŸ„αž‚αž’αŸαžŠαžŸαŸαž€αŸ’αž“αž»αž„αžŠαŸ†αžŽαžΆαž€αŸ‹αž€αžΆαž›αž’αŸ’αž„αž“αŸ‹αž’αŸ’αž„αžšαž”αžΆαž“αžŠαŸ‚αžšαž¬αž‘αŸαŸ”αž€αŸ’αž“αž»αž„αž’αŸ†αž‘αž»αž„αž–αŸαž›αž€αž·αž…αŸ’αž…αž”αŸ’αžšαž‡αž»αŸ† αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαžœαŸαž‡αŸ’αž‡αžŸαžΆαžŸαŸ’αžαŸ’αžš αž•αŸ’αž“αŸ‚αž€αž’αŸαž–αžΈαžŠαŸαž˜αžΈαžŸαžΆαžŸαŸ’αžαŸ’αžš αž“αž·αž„αžŸαž»αžαž—αžΆαž–αžŸαžΆαž’αžΆαžšαžŽαŸˆαž“αŸƒαžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αžαŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ … Read more

VIRAGE Study: FGD Progress Update

[English Below] αž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœ VIRAGEαŸ– αž”αž…αŸ’αž…αž»αž”αŸ’αž”αž“αŸ’αž“αž—αžΆαž–αž“αŸƒαž€αž·αž…αŸ’αž…αž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜αž‚αŸ„αž›αžŠαŸ… (FGD) αž…αžΆαž”αŸ‹αž–αžΈαžœαž‚αŸ’αž‚αž”αžŽαŸ’αžŠαž»αŸ‡αž”αžŽαŸ’αžŠαžΆαž›αžšαž αžΌαžαžŠαž›αŸ‹αž€αžΆαžšαž…αž»αŸ‡αžŸαž·αž€αŸ’αžŸαžΆαž•αŸ’αž‘αžΆαž›αŸ‹αž“αŸ…αž‘αžΈαžαžΆαŸ†αž„ αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαžšαž”αžŸαŸ‹αž™αžΎαž„αž€αŸ†αž–αž»αž„αžŸαŸ’αžαž·αžαž“αŸ…αžαžΆαž˜αž”αžŽαŸ’αžαžΆαžαŸαžαŸ’αžαž“αžΆαž“αžΆαž‘αžΌαž‘αžΆαŸ†αž„αž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆ αžŠαžΎαž˜αŸ’αž”αžΈαž’αŸ’αžœαžΎαž€αž·αž…αŸ’αž…αž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜ (FGDs) αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž€αžΆαžšαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž€αž½αžαŸ” αžŠαžΉαž€αž“αžΆαŸ†αžŠαŸ„αž™αžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αž‘αŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ (IPC) αž€αŸ’αž“αž»αž„αž€αž·αž…αŸ’αž…αžŸαž αž€αžΆαžšαž‡αžΆαž˜αž½αž™ αžŸαžΆαž€αž›αžœαž·αž‘αŸ’αž™αžΆαž›αŸαž™αž—αžΌαž˜αž·αž“αŸ’αž‘αž€αžŸαž·αž€αž˜αŸ’αž˜ αž“αž·αž„ αž”αžŽαŸ’αžŒαž·αžαŸ’αž™αžŸαž—αžΆαž”αž…αŸ’αž…αŸαž€αžœαž·αž‘αŸ’αž™αžΆαžŒαžΈαž‡αžΈαžαž›αž€αž˜αŸ’αž–αž»αž‡αžΆ (CADT) αžŠαŸ‚αž›αž€αžΆαžšαž„αžΆαžšαž“αŸαŸ‡αž”αžΆαž“αžšαž½αž˜αž”αž‰αŸ’αž…αžΌαž›αž‚αŸ’αž“αžΆαž“αžΌαžœαž‡αŸ†αž“αžΆαž‰αž…αž»αŸ‡αž•αŸ’αž‘αžΆαž›αŸ‹ αž€αžΆαžšαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœ αž“αž·αž„αž€αžΆαžšαžœαž·αž—αžΆαž‚αž”αŸ‚αž”αžŒαžΈαž‡αžΈαžαž› αž€αŸ’αžšαŸ„αž˜αž”αžšαž·αž”αž‘ αžŸαž»αžαž—αžΆαž–αžαŸ‚αž˜αž½αž™ (One Health)αŸ” 15/25 αžšαžΆαž‡αž’αžΆαž“αžΈ-αžαŸαžαŸ’αž αž’αŸ’αž“αž€αž‡αŸ†αž“αžΆαž‰150 αž“αžΆαž€αŸ‹ αž”αžΆαž“αž…αžΌαž›αžšαž½αž˜ αžŸαž˜αŸ’αžšαŸαž…αž”αžΆαž“ 60% αž“αŸƒαž‚αŸ„αž›αžŠαŸ…αžŸαžšαž»αž” αž™αžΎαž„αž€αŸ†αž–αž»αž„αž…αžΌαž›αžšαž½αž˜αž‡αžΆαž˜αž½αž™αž’αŸ’αž“αž€αž‡αŸ†αž“αžΆαž‰αž‡αž½αžšαž˜αž»αžαž‘αžΆαŸ†αž„αž•αŸ’αž“αŸ‚αž€αžŸαž»αžαž—αžΆαž–αž˜αž“αž»αžŸαŸ’αžŸ αž“αž·αž„αžŸαž»αžαž—αžΆαž–αžŸαžαŸ’αžœ αžŠαžΎαž˜αŸ’αž”αžΈαž–αž„αŸ’αžšαžΉαž„αž€αžΆαžšαžαžΆαž˜αžŠαžΆαž“αž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž€αž½αž αž“αž·αž„αž’αŸ’αžœαžΎαž’αŸ„αž™αž”αŸ’αžšαžŸαžΎαžšαž‘αžΎαž„αž“αžΌαžœαž€αžΆαžšαž‘αž‘αž½αž›αž”αžΆαž“αžœαŸ‰αžΆαž€αŸ‹αžŸαžΆαŸ†αž„αž”αž„αŸ’αž€αžΆαžšαž€αŸ’αžšαŸ„αž™αžŸαžαŸ’αžœαžαžΆαŸ† (PEP) αžŠαŸ‚αž›αž‡αž½αž™αžŸαž„αŸ’αž‚αŸ’αžšαŸ„αŸ‡αž‡αžΈαžœαž·αžαž’αŸ„αž™αž”αžΆαž“αž‘αžΆαž“αŸ‹αž–αŸαž›αžœαŸαž›αžΆαž“αŸ…αž‘αžΌαž‘αžΆαŸ†αž„αž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆαŸ” αž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆ VIRAGE αž“αŸαŸ‡ αž‘αž‘αž½αž›αž”αžΆαž“αž€αžΆαžšαž‚αžΆαŸ†αž‘αŸ’αžšαžŠαŸ„αž™αžŸαŸ’αžαžΆαž“αž‘αžΌαžαž”αžΆαžšαžΆαŸ†αž„αž”αŸ’αžšαž…αžΆαŸ†αž€αž˜αŸ’αž–αž»αž‡αžΆ αž“αž·αž„αž˜αžΌαž›αž“αž·αž’αž·αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαž”αžΆαžšαžΆαŸ†αž„ (Fonds Γ‰quipe France – FEF) αž“αŸƒαž€αŸ’αžšαžŸαž½αž„αž’αžΊαžšαŸ‰αž»αž” αž“αž·αž„αž€αžΆαžšαž”αžšαž‘αŸαžŸαž”αžΆαžšαžΆαŸ†αž„αŸ” VIRAGE Study: FGD Progress … Read more

VIRAGE Newsletter April Issue

As VIRAGE enters its second year, the focus shifts from research to community engagementβ€”transforming evidence into accessible rabies prevention messages through culturally grounded storytelling. Β  Published alongside the Global One Health Summit in Lyon, this marks a step from knowledge to action. Β  πŸ“„ Download the full newsletter below.Β  VIRAGE Newsletter – April

RASCMEI Newsletter April Issue

RACSMEI has completed its nationwide field survey across all 25 provinces (Dec 2025 – Apr 2026), marking a key step toward strengthening Cambodia’s capacity to detect and respond to infectious disease risks through a One Health approach. Β  This milestone was highlighted during the One Health Satellite Event in Cambodia, marking the transition from data … Read more

RACSMEI Fieldwork Enters Final Phase

[English below]Β  αžŸαŸαž…αž€αŸ’αžαžΈαžŸαž„αŸ’αžαŸαž”αž€αžΆαžšαž„αžΆαžšαž‚αž˜αŸ’αžšαŸ„αž„αžŸαž·αž€αŸ’αžŸαžΆ RACSMEI αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαž‚αž˜αŸ’αžšαŸ„αž„ RACSMEI αž€αŸ†αž–αž»αž„αžˆαžΆαž“αž…αžΌαž› αžŠαŸ†αžŽαžΆαž€αŸ‹αž€αžΆαž›αž…αž»αž„αž€αŸ’αžšαŸ„αž™αž“αŸƒαž€αžΆαžšαž”αŸ’αžšαž˜αžΌαž›αž‘αž·αž“αŸ’αž“αž“αŸαž™ αžŠαŸ„αž™αž”αžΆαž“αž”αž‰αŸ’αž…αž”αŸ‹ αž‡αžΆαž„ 8០% αž“αŸƒαž‚αŸ„αž›αžŠαŸ…αžŸαž·αž€αŸ’αžŸαžΆ αž“αŸ…αž‘αžΌαž‘αžΆαŸ†αž„αž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆαŸ” αžšαž αžΌαžαž˜αž€αžŠαž›αŸ‹αž–αŸαž›αžαŸ’αž˜αžΈαŸ—αž“αŸαŸ‡ αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαž”αžΆαž“αž…αž»αŸ‡αž”αŸ’αžšαž˜αžΌαž›αž‘αž·αž“αŸ’αž“αž“αŸαž™αžŸαžšαž»αž”αž…αŸ†αž“αž½αž“αž‡αžΆαž„ ្០ αžαŸαžαŸ’αž αžŠαŸ‚αž›αžšαž½αž˜αž˜αžΆαž“αŸ– Β  αž’αŸ’αž“αž€αž…αžΌαž›αžšαž½αž˜αžŸαžšαž»αž” 14,987 αž“αžΆαž€αŸ‹ αžŸαŸ†αžŽαžΆαž€αž–αžΈαžŸαžαŸ’αžœαžŸαžšαž»αž” 9,189 αžŸαŸ†αžŽαžΆαž€αž–αžΈαž”αžšαž·αžŸαŸ’αžαžΆαž“αžŸαžšαž»αž” (αž‘αžΉαž€ ដី αžαŸ’αž™αž›αŸ‹) 1,173 Β  αž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœ β€œαžŸαž»αžαž—αžΆαž–αžαŸ‚αž˜αž½αž™β€αž“αŸαŸ‡ αžšαž½αž˜αž”αž‰αŸ’αž…αžΌαž›αž€αž·αž…αŸ’αž…αžŸαž αž€αžΆαžšαžšαžœαžΆαž„αž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžšαž“αŸ…αž˜αž“αŸ’αž‘αžΈαžšαž–αž·αžŸαŸ„αž’αž“αŸαž‡αžΆαžαž· αž“αž·αž„αžŠαŸƒαž‚αžΌαž‡αžΆαžαž· αžŠαžΎαž˜αŸ’αž”αžΈαž™αž›αŸ‹αžŠαžΉαž„αž€αžΆαž“αŸ‹αžαŸ‚αž…αŸ’αž”αžΆαžŸαŸ‹αž’αŸ†αž–αžΈαžšαž”αŸ€αž”αžŠαŸ‚αž›αž‡αŸ†αž„αžΊαž’αžΆαž…αž•αŸ’αž‘αž»αŸ‡ αž“αž·αž„αžšαžΈαž€αžšαžΆαž›αžŠαžΆαž›αžšαžœαžΆαž„ αž˜αž“αž»αžŸαŸ’αžŸ αžŸαžαŸ’αžœ αž“αž·αž„αž”αžšαž·αžŸαŸ’αžαžΆαž“αŸ” αž›αž‘αŸ’αž’αž•αž›αž“αŸƒαž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆαž“αŸαŸ‡αž“αžΉαž„αž‡αž½αž™αž–αž„αŸ’αžšαžΉαž„αž€αžΆαžšαžαžΆαž˜αžŠαžΆαž“αž‡αŸ†αž„αžΊ αž“αž·αž„αž€αžΆαžšαž†αŸ’αž›αžΎαž™αžαž”αžŸαž»αžαž—αžΆαž–αžŸαžΆαž’αžΆαžšαžŽαŸˆαž“αŸ…αž€αž˜αŸ’αž–αž»αž‡αžΆαŸ” Β  The RACSMEI fieldwork team is entering the final phase of nationwide data collection, … Read more

IPC Participates in ANRS MIE Scientific Days

[English Below] αžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αž‘αŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ αž…αžΌαž›αžšαž½αž˜αž€αŸ’αž“αž»αž„αž€αž˜αŸ’αž˜αžœαž·αž’αžΈ ANRS MIE Scientific Days αž“αŸ…αž”αŸ’αžšαž‘αŸαžŸαžœαŸ€αžαžŽαžΆαž˜ αž“αŸ…αžαŸ’αž„αŸƒαž‘αžΈ αŸ‘αŸ β€“αŸ‘αŸ‘ αžαŸ‚αž˜αžΈαž“αžΆ αž†αŸ’αž“αžΆαŸ† ្០្៦ αž–αŸ’αžšαžΉαžαŸ’αžαž·αž€αžΆαžšαžŽαŸαžαŸ’αž„αŸƒαžœαž·αž‘αŸ’αž™αžΆαžŸαžΆαžŸαŸ’αžαŸ’αžš ANRS Emerging Infectious Diseases (ANRS MIE) αžαŸ’αžšαžΌαžœαž”αžΆαž“αžšαŸ€αž”αž…αŸ†αž‘αžΎαž„αž“αŸ…αž‘αžΈαž€αŸ’αžšαž»αž„αž αžΆαžŽαžΌαž™ αž”αŸ’αžšαž‘αŸαžŸαžœαŸ€αžαžŽαžΆαž˜ αž€αŸ’αžšαŸ„αž˜αž€αžΆαžšαžŸαž αž€αžΆαžšαžšαŸ€αž”αž…αŸ†αžŠαŸ„αž™αžŸαžΆαž€αž›αžœαž·αž‘αŸ’αž™αžΆαž›αŸαž™αžœαŸαž‡αŸ’αž‡αžŸαžΆαžŸαŸ’αžαŸ’αžšαž αžΆαžŽαžΌαž™ αž“αž·αž„αžŠαŸƒαž‚αžΌαž–αžΆαž€αŸ‹αž–αŸαž“αŸ’αž’αŸ” αž–αŸ’αžšαžΉαžαŸ’αžαž·αž€αžΆαžšαžŽαŸαž“αŸαŸ‡αž”αžΆαž“αž”αŸ’αžšαž˜αžΌαž›αž•αŸ’αžαž»αŸ†αž’αŸ’αž“αž€αžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαž–αžΈαžœαž·αžŸαŸαž™αž•αŸ’αžŸαŸαž„αŸ— αžŠαžΎαž˜αŸ’αž”αžΈαž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž’αŸ†αž–αžΈαž’αžΆαž‘αž·αž—αžΆαž–αžŸαŸ†αžαžΆαž“αŸ‹αŸ—αž“αŸƒαž‡αŸ†αž„αžΊαž†αŸ’αž›αž„αŸ” αž€αž˜αŸ’αž˜αžœαž·αž’αžΈαžšαž™αŸˆαž–αŸαž›αž–αžΈαžšαžαŸ’αž„αŸƒαž‚αžΊαž•αŸ’αžαŸ„αžαž‘αŸ…αž›αžΎαž‡αŸ†αž„αžΊαž”αž„αŸ’αž€αžšαž‘αžΎαž„αžŠαŸ„αž™αžœαžΈαžšαŸ‰αž»αžŸ β€œArbovirus” αž“αž·αž„αž‡αŸ†αž„αžΊαž‚αŸ’αžšαž»αž“αžˆαžΆαž˜αž“αŸ…αžαŸ’αž„αŸƒαž‘αžΈαž˜αž½αž™ αž“αž·αž„αž˜αŸαžšαŸ„αž‚αž’αŸαžŠαžŸαŸ αž‡αŸ†αž„αžΊαžšαž›αžΆαž€αžαŸ’αž›αžΎαž˜ αž“αž·αž„αž‡αŸ†αž„αžΊαžšαž”αŸαž„αž“αŸ…αžαŸ’αž„αŸƒαž‘αžΈαž–αžΈαžšαŸ” αž€αŸ’αž“αž»αž„αž“αžΆαž˜αž‡αžΆαžŠαŸƒαž‚αžΌαžšαž”αžŸαŸ‹ ANRS MIE αžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αž‘αŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ (IPC) αžαŸ’αžšαžΌαžœαž”αžΆαž“αž’αž‰αŸ’αž‡αžΎαž‰αž…αžΌαž›αžšαž½αž˜αž€αŸ’αž“αž»αž„αž€αž˜αŸ’αž˜αžœαž·αž’αžΈαž“αŸαŸ‡αž•αž„αžŠαŸ‚αžšαŸ” αž€αŸ’αž“αž»αž„αž’αŸ†αž‘αž»αž„αž–αŸαž›αž€αž·αž…αŸ’αž…αž”αŸ’αžšαž‡αž»αŸ† αž€αŸ’αžšαž»αž˜αžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαžœαŸαž‡αŸ’αž‡αžŸαžΆαžŸαŸ’αžαŸ’αžš αž“αŸƒαž’αž„αŸ’αž‚αž—αžΆαž–αž’αŸαž–αžΈαžŠαŸαž˜αžΈαžŸαžΆαžŸαŸ’αžαŸ’αžš αž“αž·αž„αžŸαž»αžαž—αžΆαž–αžŸαžΆαž’αžΆαžšαžŽαŸˆ αž“αŸƒαžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αž‘αŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ αž”αžΆαž“αž’αŸ’αžœαžΎαž”αž‘αž”αž„αŸ’αž αžΆαž‰αž–αžΈαž›αž‘αŸ’αž’αž•αž›αž”αž‹αž˜αž“αŸƒαž‚αž˜αŸ’αžšαŸ„αž„αžŸαž·αž€αŸ’αžŸαžΆ DATURA αžŠαŸ„αž™αž›αŸ„αž€αžœαŸαž‡αŸ’αž‡αž”αžŽαŸ’αžŒαž·αž αžŸαŸ†αžšαž·αž‘αŸ’αž’ αžŸαž»αžœαžŽαŸ’αžŽαžšαž·αž‘αŸ’αž’ αž’αŸ’αž“αž€αž’αž„αŸ’αž€αŸαžαž…αž˜αŸ’αž”αž„αž“αŸ‚αž‚αž˜αŸ’αžšαŸ„αž„αžŸαž·αž€αŸ’αžŸαžΆαž”αŸ’αžšαž…αžΆαŸ†αž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆαŸ” αž‚αž˜αŸ’αžšαŸ„αž„αžŸαž·αž€αŸ’αžŸαžΆ DATURA αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„ αž€αŸ†αžŽαžαŸ‹αžšαž€αžšαžΌαž˜αž˜αž“αŸ’αžαž–αŸ’αž™αžΆαž”αžΆαž›αž‡αŸ†αž„αžΊαžšαž”αŸαž„αžαŸ’αžšαžΉαž˜αžαŸ’αžšαžΌαžœαž›αžΎαž˜αž“αž»αžŸαŸ’αžŸαž‡αŸ†αž‘αž„αŸ‹ αž“αž·αž„αž˜αž“αž»αžŸαŸ’αžŸαž–αŸαž‰αžœαŸαž™αž•αŸ’αž‘αž»αž€αž˜αŸαžšαŸ„αž‚αž’αŸαžŠαžŸαŸαž˜αžΆαž“αž”αŸ’αžšαž–αŸαž“αŸ’αž’αž—αžΆαž–αžŸαŸŠαžΆαŸ†αž…αž»αŸ‡αžαŸ’αžŸαŸ„αž™αžαŸ’αž›αžΆαŸ†αž„αžŠαŸ‚αž›αžŸαž˜αŸ’αžšαžΆαž€αž€αŸ’αž“αž»αž„αž˜αž“αŸ’αž‘αžΈαžšαž–αŸαž‘αŸ’αž™αŸ” … Read more

RASCMEI Newsletter February 2026

The RACSMEI study aims to improve understanding of infectious diseases in Cambodia through a nationwide One Health research approach that integrates human, animal, and environmental health data. Β  The February newsletter provides updates on recent project activities, including field surveys and collaborative research efforts supporting stronger disease surveillance and evidence-based public health action. Β  πŸ“„ … Read more

VIRAGE Newsletter February Issue

The VIRAGE project continues its work to strengthen rabies prevention in Cambodia through a One Health approach that integrates human, animal, and environmental health research. By generating evidence on barriers to prevention and access to post-exposure prophylaxis (PEP), the study aims to support more effective national strategies to combat rabies. Β  This February newsletter highlights … Read more

Focus Group Discussion (FGD) Training for the VIRAGE Research Study

[English Below] αžœαž·αž‘αŸ’αž™αžΆαžŸαŸ’αžαžΆαž“αž”αŸ‰αžΆαžŸαŸ’αž‘αŸαžšαž€αž˜αŸ’αž–αž»αž‡αžΆ (IPC) αžŸαž αž€αžΆαžšαž‡αžΆαž˜αž½αž™ αžŸαžΆαž€αž›αžœαž·αž‘αŸ’αž™αžΆαž›αŸαž™αž—αžΌαž˜αž·αž“αŸ’αž‘αž€αžŸαž·αž€αž˜αŸ’αž˜ (RUA) αž“αž·αž„ αž”αžŽαŸ’αžŒαž·αžαŸ’αž™αžŸαž—αžΆαž”αž…αŸ’αž…αŸαž€αžœαž·αž‘αŸ’αž™αžΆαžŒαžΈαž‡αžΈαžαž›αž€αž˜αŸ’αž–αž»αž‡αžΆ(CADT) αž”αžΆαž“αžšαŸ€αž”αž…αŸ†αžœαž‚αŸ’αž‚αž”αžŽαŸ’αžαž»αŸ‡αž”αžŽαŸ’αžαžΆαž›αžŸαŸ’αžŠαžΈαž–αžΈαžœαž·αž’αžΈαžŸαžΆαžŸαŸ’αžαŸ’αžšαž€αžΆαžšαž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜ FGD αž“αž·αž„αž€αžΆαžšαžαžαžŸαŸ†αž‘αŸαž„αžŠαŸ‚αž›αž˜αžΆαž“αž‚αž»αžŽαž—αžΆαž–αžαŸ’αž–αžŸαŸ‹ αž‡αžΆαž•αŸ’αž“αŸ‚αž€αž˜αž½αž™αž“αŸƒαž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆ VIRAGEαŸ” αžœαž‚αŸ’αž‚αž”αžŽαŸ’αžαž»αŸ‡αž”αžŽαŸ’αžαžΆαž›αž“αŸαŸ‡αž”αžΆαž“αž–αž„αŸ’αžšαžΉαž„αž‡αŸ†αž“αžΆαž‰αž’αŸ’αž“αž€αžŸαž˜αŸ’αžšαž”αžŸαž˜αŸ’αžšαž½αž›αž€αŸ’αž“αž»αž„αž€αžΆαžšαž”αŸ’αžšαž˜αžΌαž›αž‘αž·αž“αŸ’αž“αž“αŸαž™αž”αŸ‚αž”αž‚αž»αžŽαžœαž·αžŸαŸαž™ αž”αž‰αŸ’αž‡αžΆαž€αŸ‹αžαž½αž“αžΆαž‘αžΈαž€αŸ’αžšαž»αž˜αž€αžΆαžšαž„αžΆαžš αž“αž·αž„αž’αžΆαž“αžΆαž‚αž»αžŽαž—αžΆαž–αžαžαžŸαŸ†αž‘αŸαž„αž›αŸ’αž’αž”αŸ†αž•αž»αžαžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž€αžΆαžšαž…αž˜αŸ’αž›αž„αž’αžαŸ’αžαž”αž‘ αž“αž·αž„αžœαž·αž—αžΆαž‚αž‘αž·αž“αŸ’αž“αž“αŸαž™αž”αžΆαž“αžαŸ’αžšαžΉαž˜αžαŸ’αžšαžΌαžœαŸ” αž€αžΆαžšαž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜αž“αžΆαž–αŸαž›αžαžΆαž„αž˜αž»αž αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž’αŸ†αž–αžΈαž€αžαŸ’αžαžΆαž‡αŸ†αžšαž»αž‰ αž“αž·αž„αž§αž”αžŸαž‚αŸ’αž‚αž€αŸ’αž“αž»αž„αž€αžΆαžšαžαžΆαž˜αžŠαžΆαž“αž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž€αž½αž αž“αž·αž„αž‘αž‘αž½αž›αžŸαŸαžœαžΆαžαŸ’αž“αžΆαŸ†αž”αž„αŸ’αž€αžΆαžšαž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž‚αž½αžαž€αŸ’αžšαŸ„αž™αžŸαžαŸ’αžœαžαžΆαŸ† (PEP)αŸ” αž…αžΆαž”αŸ‹αž–αžΈαž–αžΆαž€αŸ‹αž€αžŽαŸ’αžαžΆαž›αžαŸ‚αž˜αžΈαž“αžΆ αžŠαž›αŸ‹αž–αžΆαž€αŸ‹αž€αžŽαŸ’αžαžΆαž›αžαŸ‚αž§αžŸαž—αžΆ αžŸαžΆαž€αž›αžœαž·αž‘αŸ’αž™αžΆαž›αŸαž™αž—αžΌαž˜αž·αž“αŸ’αž‘αž€αžŸαž·αž€αž˜αŸ’αž˜ (RUA) αž“αžΉαž„αž’αž“αž»αžœαžαŸ’αžαž€αžΆαžšαž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜αž“αŸαŸ‡αž“αŸ…αž‘αžΌαž‘αžΆαŸ†αž„ ្αŸ₯ αžαŸαžαŸ’αžαžšαžΆαž‡αž’αžΆαž“αžΈαž“αŸƒαž”αŸ’αžšαž‘αŸαžŸαž€αž˜αŸ’αž–αž»αž‡αžΆ αžŠαŸ„αž™αž…αžΌαž›αžšαž½αž˜αž–αžΈαž’αŸ’αž“αž€αž‡αŸ†αž“αžΆαž‰αž•αŸ’αž“αŸ‚αž€αžŸαž»αžαž—αžΆαž–αž˜αž“αž»αžŸαŸ’αžŸ αž“αž·αž„αžŸαžαŸ’αžœ αž“αŸ…αž€αž˜αŸ’αžšαž·αžαžαŸ’αž“αžΆαž€αŸ‹αžαŸαžαŸ’αž αž“αž·αž„αžŸαŸ’αžšαž»αž€αŸ” αž›αž‘αŸ’αž’αž•αž›αžŠαŸ‚αž›αžšαŸ†αž–αžΉαž„αž‘αž»αž€αŸ– αž€αžΆαžšαž–αž·αž—αžΆαž€αŸ’αžŸαžΆαž€αŸ’αžšαž»αž˜αžŠαŸ‚αž›αžŠαžΉαž€αž“αžΆαŸ†αž”αžΆαž“αž™αŸ‰αžΆαž„αž›αŸ’αž’αž“αž·αž„αž˜αžΆαž“αž”αŸ’αžšαžŸαž·αž‘αŸ’αž’αž—αžΆαž– αž€αžΆαžšαžαžαžŸαŸ†αž‘αŸαž„αž˜αžΆαž“αž‚αž»αžŽαž—αžΆαž–αžαŸ’αž–αžŸαŸ‹αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž€αžΆαžšαž…αž˜αŸ’αž›αž„αž’αžαŸ’αžαž”αž‘αž”αžΆαž“αžαŸ’αžšαžΉαž˜αžαŸ’αžšαžΌαžœ αž‘αž·αž“αŸ’αž“αž“αŸαž™αž”αŸ‚αž”αž‚αž»αžŽαžœαž·αžŸαŸαž™αžŠαŸ‚αž›αž’αžΆαž…αž‘αž»αž€αž…αž·αžαŸ’αžαž”αžΆαž“αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž€αžΆαžšαžœαž·αž—αžΆαž‚αžŸαŸŠαžΈαž‡αž˜αŸ’αžšαŸ… αž—αžŸαŸ’αžαž»αžαžΆαž„αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž‚αžΆαŸ†αž‘αŸ’αžšαž“αž·αž„αž–αž„αŸ’αžšαžΉαž„αž™αž»αž‘αŸ’αž’αžŸαžΆαžŸαŸ’αžαŸ’αžšαžŸαž»αžαž—αžΆαž–αžŸαžΆαž’αžΆαžšαžŽαŸˆ αž€αžΆαžšαž’αž“αž»αžœαžαŸ’αžαž€αžΆαžšαžŸαž·αž€αŸ’αžŸαžΆαž‘αžΌαž‘αžΆαŸ†αž„αž”αŸ’αžšαž‘αŸαžŸαž“αŸαŸ‡ αž“αžΉαž„αž”αž„αŸ’αž€αžΎαžαž€αžΆαžšαž™αž›αŸ‹αžŠαžΉαž„αžŸαŸ†αžαžΆαž“αŸ‹αŸ— αžŠαžΎαž˜αŸ’αž”αžΈαž€αŸ‚αž›αž˜αŸ’αž’αž€αžΆαžšαžαžΆαž˜αžŠαžΆαž“αž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž€αž½αž αž“αž·αž„αž”αž„αŸ’αž€αžΎαž“αž€αžΆαžšαž‘αž‘αž½αž›αžŸαŸαžœαžΆαžαŸ’αž“αžΆαŸ†αž”αž„αŸ’αž€αžΆαžšαž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž‚αž½αžαž€αŸ’αžšαŸ„αž™αžŸαžαŸ’αžœαžαžΆαŸ† (PEP) αž–αŸ’αžšαž˜αž‘αžΆαŸ†αž„αž–αž„αŸ’αžšαžΉαž„αž€αž·αž…αŸ’αž…αžŸαž αž€αžΆαžšαž”αŸ’αžšαž–αŸαž“αŸ’αž’αžŸαž»αžαž—αžΆαž–αžαžΆαž˜αž”αžšαž·αž”αž‘αžŸαž»αžαž—αžΆαž–αžαŸ‚αž˜αž½αž™ (One Health) αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž€αžΆαžšαž€αžΆαžšαž–αžΆαžšαž‡αŸ†αž„αžΊαž†αŸ’αž€αŸ‚αž†αŸ’αž€αž½αžαž“αŸ…αž€αž˜αŸ’αž–αž»αž‡αžΆαŸ” αž€αž˜αŸ’αž˜αžœαž·αž’αžΈαžŸαž·αž€αŸ’αžŸαžΆαžŸαŸ’αžšαžΆαžœαž‡αŸ’αžšαžΆαžœαž“αŸαŸ‡ αž‘αž‘αž½αž›αž”αžΆαž“αž€αžΆαžšαž‚αžΆαŸ†αž‘αŸ’αžšαž–αžΈαž˜αžΌαž›αž“αž·αž’αž·αž”αžΆαžšαžΆαŸ†αž„ (Fonds Γ‰quipe France – FEF) … Read more